1. Home
  2. NHI vs ADMA Comparison

NHI vs ADMA Comparison

Compare NHI & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Health Investors Inc.

NHI

National Health Investors Inc.

HOLD

Current Price

$86.29

Market Cap

4.1B

Sector

Real Estate

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$15.83

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHI
ADMA
Founded
1991
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.6B
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
NHI
ADMA
Price
$86.29
$15.83
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$87.00
$32.00
AVG Volume (30 Days)
274.0K
3.3M
Earning Date
05-29-2026
05-15-2026
Dividend Yield
4.32%
N/A
EPS Growth
N/A
N/A
EPS
3.02
0.60
Revenue
$375,628,000.00
$42,219,783.00
Revenue This Year
$11.74
$27.46
Revenue Next Year
$9.02
$21.11
P/E Ratio
$28.20
$25.24
Revenue Growth
12.07
43.85
52 Week Low
$66.41
$13.76
52 Week High
$91.38
$25.67

Technical Indicators

Market Signals
Indicator
NHI
ADMA
Relative Strength Index (RSI) 53.81 47.88
Support Level $77.64 $15.35
Resistance Level $91.38 $16.28
Average True Range (ATR) 2.10 0.81
MACD -0.36 0.01
Stochastic Oscillator 58.61 48.08

Price Performance

Historical Comparison
NHI
ADMA

About NHI National Health Investors Inc.

National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: